Track topics on Twitter Track topics that are important to you
Eisai Inc., the U.S. subsidiary of Tokyo, Japan-based Eisai Co., Ltd., has entered into a new joint research agreement with the Broad Institute, a collaborative research institute which includes researchers from the Massachusetts Institute of Technology and Harvard University, to develop a new antimalarial medicine based on anti-malarial drug targets the team identified last year. The Eisai and Broad Joint […]
The post Eisai, Broad Institute to develop an antimalarial medicine appeared first on CenterWatch News Online.
Original Article: Eisai, Broad Institute to develop an antimalarial medicineNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...